Scholars Central

Search Scholars Central

Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.

Advanced searchHide advanced search

In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:

Years

1–25 of 72 articles for Apixaban

Then save them, add them to a collection or cite them together.
  1. Research article · 23 Sep 2020

    Switch To Heparin and Risk of Bleeding In Patients on Apixaban Undergoing Cardiac Rhythm Procedures: The Amper Af Study

    Journal of Thrombosis and Circulation: Open Access · Volume 6, Issue 4

    real-life management of patients undergoing cardiac rhythm procedures and therapies while receiving apixaban. Methods: This observational, multicentre study prospectively collected data from patients with non valvular…

  2. Research article · 25 Nov 2017

    METHOD DEVELOPMENT AND VALIDATION OF APIXABAN USING RP-HPLC METHOD AND ITS STRESS STABILITY STUDIES

    International Journal of Chemical and Pharmaceutical Analysis · Volume 5, Issue 1

    chromatographic method (RP-HPLC) good sensitivity was determined for the development and validation of Apixaban. In Water Apixaban λmax was fixed as 259nm using a Shimadzu UV-Visible spectrophotometer ... rate and…

  3. Research article · 28 Feb 2023

    Safety of Direct Acting Oral Anticoagulants (DOACs) in Comparison to Enoxaparin in Gastrointestinal and Genito-Urinary Cancers

    Journal of Basic and Clinical Pharmacy · Volume 14, Issue 1

    patients with active GI and GU malignancies who received either enoxaparin or a DOAC (apixaban or rivaroxaban) for CAT from July 2001 to July 2020. Demographics, disease characteristics, thrombosis data ... year were…

  4. Research article · 2015

    Economic Evaluations of Medical Cost Differences: Use of Targeted-Specific Oral Anticoagulants vs. Warfarin among Patients with Nonvalvular Atrial Fibrillation and Venous Thromboembolism in the U.S.

    Journal of Hematology & Thromboembolic Diseases · Volume 3, Issue 3

    each of the four targeted-specific oral anticoagulants (TSOACs), dabigatran, rivaroxaban, apixaban, and edoxaban vs. warfarin for the treatment of nonvalvular atrial fibrillation (NVAF) and venous thromboembolism (VTE)…

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels